5Wang SM, Liu CC. Enterovirus 71 : epidemiology, pathogenesis andmanagement[ J]. Expert Rev Anti Infect Ther,2009,7(6) :735 - 742.
6Miyazawa I, Azegami Y, Kasuo S, et al . Prevalence of enterovirusfrom patients with herpangina and hand, foot and mouth disease inNagano Prefecture, Japan,2007 [ J ]. Jpn J Infect Dis, 2008,61(3) :247 -248.
7Yi L,He Y,Chen Y, et al . Potent inhibition of human enterovirus71 replication by type I interferon subtypes [ J ]. Antivir Ther,2011,16(1) :51 -58.
8Michuel G,Ison A, John Mills B y et al . Current research on respira-tory viral infections[ J]. Antiviral Res,2002,55(2) :227 -278.
10Moss RB, Mayer-Hamblett N, Wagener J, et al . Randomized,double-blind,placebo-controlled, dose-escalating study of aero-solized interferon gamma-1 b in patients with mild to moderatecystic fibrosis lung disease[ J]. Pediatr Pulmonol,2005,39 ( 3 ):209 -218.
